FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, namely to a tissue engineering structure for filling the bone tissue of the maxillofacial region. Construct comprises donor multipotent mesenchymal stromal cells on a carrier, which is represented by 150–200 mcm octacalcium phosphate granules with pore size of 1–5 mcm, on the surface of which there are incubated multipotent mesenchymal stromal cells obtained from the patient's gingival biopsy material and cultivated on a medium of aqueous sol of nanocrystalline cerium dioxide stabilized with citrate ions in concentration of (10–4) - (10–9) M, wherein concentration of multipotent mesenchymal stromal cells is 2 × 107 cells per 1 g of carrier.
EFFECT: invention widens the range of equipment.
1 cl
| Title | Year | Author | Number |
|---|---|---|---|
| TISSUE-BIOENGINEERING DESIGN FOR REPLENISHING VOLUME OF BONE TISSUE OF JAW BONES | 2022 |
|
RU2809154C1 |
| BIOCOMPLEX FOR STIMULATION OF MICROARCHITHEONICS RESTORATION OF BONE TISSUE OF MAXILLOFACIAL AREA | 2019 |
|
RU2726821C1 |
| METHOD FOR JAW BONE TISSUE REGENERATION | 2019 |
|
RU2709723C1 |
| NANODISPERSED PLASTIC BIOENGINEERING COMPOSITION BASED ON CERIUM DIOXIDE FOR REPLENISHING THE VOLUME OF BONE TISSUE | 2021 |
|
RU2793324C1 |
| BIOCOMPLEX TO STIMULATE TISSUE REGENERATION AND REMODELING | 2021 |
|
RU2794464C1 |
| BIOTRANSPLANT FOR RECOVERY OF BONE TISSUE VOLUME IN CASE OF DEGENERATIVE DISEASES AND TRAUMATIC INJURIES OF BONES AND METHOD OF OBTAINING THEREOF | 2012 |
|
RU2530622C2 |
| BIOTRANSPLANT, METHOD FOR MAKING THEREOF AND METHOD OF TREATING DEGENERATIVE AND TRAUMATIC DISEASES OF MAXILLOFACIAL BONE TISSUE | 2008 |
|
RU2380105C1 |
| METHOD FOR DENTAL IMPLANTATION IN PATIENTS WITH EPILEPSY | 2020 |
|
RU2753240C1 |
| NANODISPERSED CERAMIC BIODEGRADABLE MATERIAL FOR JAW BONE DEFECT REPLACEMENT | 2022 |
|
RU2824854C2 |
| METHOD FOR TREATMENT OF CHRONIC PERIODONTITIS USING MESENCHYMAL STEM CELLS OF ADIPOSE TISSUE | 2022 |
|
RU2791194C1 |
